<html xmlns:mims="http://www.mims.com"><head><link type="text/css" href="../css/redmond/jquery-ui-1.8.6.custom.css" rel="stylesheet" /><link type="text/css" href="../css/mims.css" rel="stylesheet" /><script type="text/javascript" src="../scripts/jquery-1.4.4.min.js"></script><script type="text/javascript" src="../scripts/jquery-ui-1.8.6.custom.min.js"></script><script type="text/javascript" src="../scripts/drugalert.js"></script></head><body><div id="tabs" class="tab-container"><ul><li><a href="#tab-interaction">Drug Interaction (16)</a></li><li><a href="#tab-allergy">Allergy (8)</a></li></ul><div id="tab-interaction" class="acc_container"><div id="list_interactions"><div id="i_4_diclofenac_sodium_spironolactone"><h3><a href="#"><table class="severity"><tr><td class="severity4"></td></tr></table> 
	DICLOFEN TAB 50mg (diclofenac sodium/Systemic) vs SPILACTONE FILM-COATED TAB 50mg (spironolactone/Systemic)
					</a></h3><div><h4 class="subheading">Interaction Effect</h4><p>diclofenac sodium reduces effect of spironolactone</p><h4 class="subheading">Severity Level</h4><p><em>Moderate</em> - </p><h4 class="subheading">Documentation Level</h4><p><em>Good</em> - </p><button name="_ref" id="_br_i_4_diclofenac_sodium_spironolactone">Read more </button><div id="r_i_4_diclofenac_sodium_spironolactone" style="display: none"><h4 class="subheading">Probable Mechanism</h4>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.<h4 class="subheading">Actions to be taken</h4><ol><li>Use combination with caution.</li><li>Monitor renal function.</li><li>Monitor serum potassium.</li><li>Monitor blood pressure.</li></ol></div></div></div><div id="i_4_diclofenac_sodium_spironolactone"><h3><a href="#"><table class="severity"><tr><td class="severity4"></td></tr></table> 
	DICLOFEN TAB 50mg (diclofenac sodium/Systemic) vs SPILACTONE FILM-COATED TAB 50mg (spironolactone/Systemic)
					</a></h3><div><h4 class="subheading">Interaction Effect</h4><p>diclofenac sodium reduces effect of spironolactone</p><h4 class="subheading">Severity Level</h4><p><em>Moderate</em> - </p><h4 class="subheading">Documentation Level</h4><p><em>Good</em> - </p><button name="_ref" id="_br_i_4_diclofenac_sodium_spironolactone">Read more </button><div id="r_i_4_diclofenac_sodium_spironolactone" style="display: none"><h4 class="subheading">Probable Mechanism</h4>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.<h4 class="subheading">Actions to be taken</h4><ol><li>Use combination with caution.</li><li>Monitor renal function.</li><li>Monitor serum potassium.</li><li>Monitor blood pressure.</li></ol></div></div></div><div id="i_4_diclofenac_sodium_spironolactone"><h3><a href="#"><table class="severity"><tr><td class="severity4"></td></tr></table> 
	DICLOFEN TAB 50mg (diclofenac sodium/Systemic) vs SPILACTONE FILM-COATED TAB 50mg (spironolactone/Systemic)
					</a></h3><div><h4 class="subheading">Interaction Effect</h4><p>diclofenac sodium reduces effect of spironolactone</p><h4 class="subheading">Severity Level</h4><p><em>Moderate</em> - </p><h4 class="subheading">Documentation Level</h4><p><em>Good</em> - </p><button name="_ref" id="_br_i_4_diclofenac_sodium_spironolactone">Read more </button><div id="r_i_4_diclofenac_sodium_spironolactone" style="display: none"><h4 class="subheading">Probable Mechanism</h4>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.<h4 class="subheading">Actions to be taken</h4><ol><li>Use combination with caution.</li><li>Monitor renal function.</li><li>Monitor serum potassium.</li><li>Monitor blood pressure.</li></ol></div></div></div><div id="i_4_diclofenac_sodium_spironolactone"><h3><a href="#"><table class="severity"><tr><td class="severity4"></td></tr></table> 
	DICLOFEN TAB 50mg (diclofenac sodium/Systemic) vs SPILACTONE FILM-COATED TAB 50mg (spironolactone/Systemic)
					</a></h3><div><h4 class="subheading">Interaction Effect</h4><p>diclofenac sodium reduces effect of spironolactone</p><h4 class="subheading">Severity Level</h4><p><em>Moderate</em> - </p><h4 class="subheading">Documentation Level</h4><p><em>Good</em> - </p><button name="_ref" id="_br_i_4_diclofenac_sodium_spironolactone">Read more </button><div id="r_i_4_diclofenac_sodium_spironolactone" style="display: none"><h4 class="subheading">Probable Mechanism</h4>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.<h4 class="subheading">Actions to be taken</h4><ol><li>Use combination with caution.</li><li>Monitor renal function.</li><li>Monitor serum potassium.</li><li>Monitor blood pressure.</li></ol></div></div></div><div id="i_4_diclofenac_sodium_spironolactone"><h3><a href="#"><table class="severity"><tr><td class="severity4"></td></tr></table> 
	DICLOFEN TAB 50mg (diclofenac sodium/Systemic) vs SPILACTONE FILM-COATED TAB 50mg (spironolactone/Systemic)
					</a></h3><div><h4 class="subheading">Interaction Effect</h4><p>diclofenac sodium reduces effect of spironolactone</p><h4 class="subheading">Severity Level</h4><p><em>Moderate</em> - </p><h4 class="subheading">Documentation Level</h4><p><em>Good</em> - </p><button name="_ref" id="_br_i_4_diclofenac_sodium_spironolactone">Read more </button><div id="r_i_4_diclofenac_sodium_spironolactone" style="display: none"><h4 class="subheading">Probable Mechanism</h4>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.<h4 class="subheading">Actions to be taken</h4><ol><li>Use combination with caution.</li><li>Monitor renal function.</li><li>Monitor serum potassium.</li><li>Monitor blood pressure.</li></ol></div></div></div><div id="i_4_diclofenac_sodium_spironolactone"><h3><a href="#"><table class="severity"><tr><td class="severity4"></td></tr></table> 
	DICLOFEN TAB 50mg (diclofenac sodium/Systemic) vs SPILACTONE FILM-COATED TAB 50mg (spironolactone/Systemic)
					</a></h3><div><h4 class="subheading">Interaction Effect</h4><p>diclofenac sodium reduces effect of spironolactone</p><h4 class="subheading">Severity Level</h4><p><em>Moderate</em> - </p><h4 class="subheading">Documentation Level</h4><p><em>Good</em> - </p><button name="_ref" id="_br_i_4_diclofenac_sodium_spironolactone">Read more </button><div id="r_i_4_diclofenac_sodium_spironolactone" style="display: none"><h4 class="subheading">Probable Mechanism</h4>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.<h4 class="subheading">Actions to be taken</h4><ol><li>Use combination with caution.</li><li>Monitor renal function.</li><li>Monitor serum potassium.</li><li>Monitor blood pressure.</li></ol></div></div></div><div id="i_4_diclofenac_sodium_spironolactone"><h3><a href="#"><table class="severity"><tr><td class="severity4"></td></tr></table> 
	DICLOFEN TAB 50mg (diclofenac sodium/Systemic) vs SPILACTONE FILM-COATED TAB 50mg (spironolactone/Systemic)
					</a></h3><div><h4 class="subheading">Interaction Effect</h4><p>diclofenac sodium reduces effect of spironolactone</p><h4 class="subheading">Severity Level</h4><p><em>Moderate</em> - </p><h4 class="subheading">Documentation Level</h4><p><em>Good</em> - </p><button name="_ref" id="_br_i_4_diclofenac_sodium_spironolactone">Read more </button><div id="r_i_4_diclofenac_sodium_spironolactone" style="display: none"><h4 class="subheading">Probable Mechanism</h4>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.<h4 class="subheading">Actions to be taken</h4><ol><li>Use combination with caution.</li><li>Monitor renal function.</li><li>Monitor serum potassium.</li><li>Monitor blood pressure.</li></ol></div></div></div><div id="i_4_diclofenac_sodium_spironolactone"><h3><a href="#"><table class="severity"><tr><td class="severity4"></td></tr></table> 
	DICLOFEN TAB 50mg (diclofenac sodium/Systemic) vs SPILACTONE FILM-COATED TAB 50mg (spironolactone/Systemic)
					</a></h3><div><h4 class="subheading">Interaction Effect</h4><p>diclofenac sodium reduces effect of spironolactone</p><h4 class="subheading">Severity Level</h4><p><em>Moderate</em> - </p><h4 class="subheading">Documentation Level</h4><p><em>Good</em> - </p><button name="_ref" id="_br_i_4_diclofenac_sodium_spironolactone">Read more </button><div id="r_i_4_diclofenac_sodium_spironolactone" style="display: none"><h4 class="subheading">Probable Mechanism</h4>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.<h4 class="subheading">Actions to be taken</h4><ol><li>Use combination with caution.</li><li>Monitor renal function.</li><li>Monitor serum potassium.</li><li>Monitor blood pressure.</li></ol></div></div></div><div id="i_4_diclofenac_sodium_spironolactone"><h3><a href="#"><table class="severity"><tr><td class="severity4"></td></tr></table> 
	DICLOFEN TAB 50mg (diclofenac sodium/Systemic) vs SPILACTONE FILM-COATED TAB 50mg (spironolactone/Systemic)
					</a></h3><div><h4 class="subheading">Interaction Effect</h4><p>diclofenac sodium reduces effect of spironolactone</p><h4 class="subheading">Severity Level</h4><p><em>Moderate</em> - </p><h4 class="subheading">Documentation Level</h4><p><em>Good</em> - </p><button name="_ref" id="_br_i_4_diclofenac_sodium_spironolactone">Read more </button><div id="r_i_4_diclofenac_sodium_spironolactone" style="display: none"><h4 class="subheading">Probable Mechanism</h4>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.<h4 class="subheading">Actions to be taken</h4><ol><li>Use combination with caution.</li><li>Monitor renal function.</li><li>Monitor serum potassium.</li><li>Monitor blood pressure.</li></ol></div></div></div><div id="i_4_diclofenac_sodium_spironolactone"><h3><a href="#"><table class="severity"><tr><td class="severity4"></td></tr></table> 
	DICLOFEN TAB 50mg (diclofenac sodium/Systemic) vs SPILACTONE FILM-COATED TAB 50mg (spironolactone/Systemic)
					</a></h3><div><h4 class="subheading">Interaction Effect</h4><p>diclofenac sodium reduces effect of spironolactone</p><h4 class="subheading">Severity Level</h4><p><em>Moderate</em> - </p><h4 class="subheading">Documentation Level</h4><p><em>Good</em> - </p><button name="_ref" id="_br_i_4_diclofenac_sodium_spironolactone">Read more </button><div id="r_i_4_diclofenac_sodium_spironolactone" style="display: none"><h4 class="subheading">Probable Mechanism</h4>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.<h4 class="subheading">Actions to be taken</h4><ol><li>Use combination with caution.</li><li>Monitor renal function.</li><li>Monitor serum potassium.</li><li>Monitor blood pressure.</li></ol></div></div></div><div id="i_4_diclofenac_sodium_spironolactone"><h3><a href="#"><table class="severity"><tr><td class="severity4"></td></tr></table> 
	DICLOFEN TAB 50mg (diclofenac sodium/Systemic) vs SPILACTONE FILM-COATED TAB 50mg (spironolactone/Systemic)
					</a></h3><div><h4 class="subheading">Interaction Effect</h4><p>diclofenac sodium reduces effect of spironolactone</p><h4 class="subheading">Severity Level</h4><p><em>Moderate</em> - </p><h4 class="subheading">Documentation Level</h4><p><em>Good</em> - </p><button name="_ref" id="_br_i_4_diclofenac_sodium_spironolactone">Read more </button><div id="r_i_4_diclofenac_sodium_spironolactone" style="display: none"><h4 class="subheading">Probable Mechanism</h4>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.<h4 class="subheading">Actions to be taken</h4><ol><li>Use combination with caution.</li><li>Monitor renal function.</li><li>Monitor serum potassium.</li><li>Monitor blood pressure.</li></ol></div></div></div><div id="i_4_diclofenac_sodium_spironolactone"><h3><a href="#"><table class="severity"><tr><td class="severity4"></td></tr></table> 
	DICLOFEN TAB 50mg (diclofenac sodium/Systemic) vs SPILACTONE FILM-COATED TAB 50mg (spironolactone/Systemic)
					</a></h3><div><h4 class="subheading">Interaction Effect</h4><p>diclofenac sodium reduces effect of spironolactone</p><h4 class="subheading">Severity Level</h4><p><em>Moderate</em> - </p><h4 class="subheading">Documentation Level</h4><p><em>Good</em> - </p><button name="_ref" id="_br_i_4_diclofenac_sodium_spironolactone">Read more </button><div id="r_i_4_diclofenac_sodium_spironolactone" style="display: none"><h4 class="subheading">Probable Mechanism</h4>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.<h4 class="subheading">Actions to be taken</h4><ol><li>Use combination with caution.</li><li>Monitor renal function.</li><li>Monitor serum potassium.</li><li>Monitor blood pressure.</li></ol></div></div></div><div id="i_4_diclofenac_sodium_spironolactone"><h3><a href="#"><table class="severity"><tr><td class="severity4"></td></tr></table> 
	DICLOFEN TAB 50mg (diclofenac sodium/Systemic) vs SPILACTONE FILM-COATED TAB 50mg (spironolactone/Systemic)
					</a></h3><div><h4 class="subheading">Interaction Effect</h4><p>diclofenac sodium reduces effect of spironolactone</p><h4 class="subheading">Severity Level</h4><p><em>Moderate</em> - </p><h4 class="subheading">Documentation Level</h4><p><em>Good</em> - </p><button name="_ref" id="_br_i_4_diclofenac_sodium_spironolactone">Read more </button><div id="r_i_4_diclofenac_sodium_spironolactone" style="display: none"><h4 class="subheading">Probable Mechanism</h4>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.<h4 class="subheading">Actions to be taken</h4><ol><li>Use combination with caution.</li><li>Monitor renal function.</li><li>Monitor serum potassium.</li><li>Monitor blood pressure.</li></ol></div></div></div><div id="i_4_diclofenac_sodium_spironolactone"><h3><a href="#"><table class="severity"><tr><td class="severity4"></td></tr></table> 
	DICLOFEN TAB 50mg (diclofenac sodium/Systemic) vs SPILACTONE FILM-COATED TAB 50mg (spironolactone/Systemic)
					</a></h3><div><h4 class="subheading">Interaction Effect</h4><p>diclofenac sodium reduces effect of spironolactone</p><h4 class="subheading">Severity Level</h4><p><em>Moderate</em> - </p><h4 class="subheading">Documentation Level</h4><p><em>Good</em> - </p><button name="_ref" id="_br_i_4_diclofenac_sodium_spironolactone">Read more </button><div id="r_i_4_diclofenac_sodium_spironolactone" style="display: none"><h4 class="subheading">Probable Mechanism</h4>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.<h4 class="subheading">Actions to be taken</h4><ol><li>Use combination with caution.</li><li>Monitor renal function.</li><li>Monitor serum potassium.</li><li>Monitor blood pressure.</li></ol></div></div></div><div id="i_4_diclofenac_sodium_spironolactone"><h3><a href="#"><table class="severity"><tr><td class="severity4"></td></tr></table> 
	DICLOFEN TAB 50mg (diclofenac sodium/Systemic) vs SPILACTONE FILM-COATED TAB 50mg (spironolactone/Systemic)
					</a></h3><div><h4 class="subheading">Interaction Effect</h4><p>diclofenac sodium reduces effect of spironolactone</p><h4 class="subheading">Severity Level</h4><p><em>Moderate</em> - </p><h4 class="subheading">Documentation Level</h4><p><em>Good</em> - </p><button name="_ref" id="_br_i_4_diclofenac_sodium_spironolactone">Read more </button><div id="r_i_4_diclofenac_sodium_spironolactone" style="display: none"><h4 class="subheading">Probable Mechanism</h4>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.<h4 class="subheading">Actions to be taken</h4><ol><li>Use combination with caution.</li><li>Monitor renal function.</li><li>Monitor serum potassium.</li><li>Monitor blood pressure.</li></ol></div></div></div><div id="i_4_diclofenac_sodium_spironolactone"><h3><a href="#"><table class="severity"><tr><td class="severity4"></td></tr></table> 
	DICLOFEN TAB 50mg (diclofenac sodium/Systemic) vs SPILACTONE FILM-COATED TAB 50mg (spironolactone/Systemic)
					</a></h3><div><h4 class="subheading">Interaction Effect</h4><p>diclofenac sodium reduces effect of spironolactone</p><h4 class="subheading">Severity Level</h4><p><em>Moderate</em> - </p><h4 class="subheading">Documentation Level</h4><p><em>Good</em> - </p><button name="_ref" id="_br_i_4_diclofenac_sodium_spironolactone">Read more </button><div id="r_i_4_diclofenac_sodium_spironolactone" style="display: none"><h4 class="subheading">Probable Mechanism</h4>Coadministration of diuretics with nonsteroidal anti-inflammatory drugs (NSAIDs)may reduce the antihypertensive and diuretic effects of diuretics. This may be due to impaired prostaglandin synthesis which may lead to salt and water retention. Studies have shown that concurrent use led to decreased natriuretic effects of diuretics. Additionally, NSAIDs also have nephrotoxic effects which may be exacerbated by diuretic therapy. The addition of an ACE inhibitor to this combination (NSAID + diuretic) will further increase the risk of renal impairment, especially in the elderly. Monitor concurrent use and increase the dose of diuretic if needed.<h4 class="subheading">Actions to be taken</h4><ol><li>Use combination with caution.</li><li>Monitor renal function.</li><li>Monitor serum potassium.</li><li>Monitor blood pressure.</li></ol></div></div></div></div></div><div id="tab-allergy" class="acc_container"><div id="list_allergies"><div id="a_paracetamol"><h3><a href="#">Patient may be allergic to the prescribing item, DICLOFEN TAB 50mg.</a></h3><div><div><h4 class="subheading">Allergy history:</h4><ul class="NoBulletNoIndent"><li>The patient has a known history of allergic reaction to Molecule, <em>paracetamol</em>.</li><li><em>DICLOFEN TAB 50mg</em> contains <em>diclofenac sodium</em>, which is cross-sensitive to <em>paracetamol</em>.</li></ul></div></div></div></div></div></div></body></html>